1. Xu, Jingyue, Liu, Han, Lan, Yu, Jiang, Rulang. 2021. Cis-Repression of Foxq1 Expression Affects Foxf2-Mediated Gene Expression in Palate Development. In Frontiers in cell and developmental biology, 9, 665109. doi:10.3389/fcell.2021.665109. https://pubmed.ncbi.nlm.nih.gov/33898467/
2. Jia, Deyong, Zhou, Zhicheng, Kwon, Oh-Joon, Creighton, Chad J, Xin, Li. 2022. Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunity. In Nature communications, 13, 6828. doi:10.1038/s41467-022-34665-z. https://pubmed.ncbi.nlm.nih.gov/36369237/
3. Ryu, Jae-Ryeon, Ahuja, Suchit, Arnold, Corey R, Debette, Stéphanie, Childs, Sarah J. 2022. Stroke-associated intergenic variants modulate a human FOXF2 transcriptional enhancer. In Proceedings of the National Academy of Sciences of the United States of America, 119, e2121333119. doi:10.1073/pnas.2121333119. https://pubmed.ncbi.nlm.nih.gov/35994645/
4. Zhang, Cheng, Li, Yong-Zhi, Dai, Dong-Qiu. 2021. Aberrant DNA Methylation-Mediated FOXF2 Dysregulation Is a Prognostic Risk Factor for Gastric Cancer. In Frontiers in molecular biosciences, 8, 645470. doi:10.3389/fmolb.2021.645470. https://pubmed.ncbi.nlm.nih.gov/34568422/
5. Liu, Limin, Chen, Guobin, Chen, Taoliang, Cai, Huihua, He, Yuanli. 2020. si-SNHG5-FOXF2 inhibits TGF-β1-induced fibrosis in human primary endometrial stromal cells by the Wnt/β-catenin signalling pathway. In Stem cell research & therapy, 11, 479. doi:10.1186/s13287-020-01990-3. https://pubmed.ncbi.nlm.nih.gov/33176855/
6. Zhang, Xiao, Zhang, Rui, Hou, Chen, Zhai, Qiong-Li, Feng, Yu-Mei. 2022. FOXF2 oppositely regulates stemness in luminal and basal-like breast cancer cells through the Wnt/beta-catenin pathway. In The Journal of biological chemistry, 298, 102082. doi:10.1016/j.jbc.2022.102082. https://pubmed.ncbi.nlm.nih.gov/35660418/